1887

n CME : Your SA Journal of CPD - Haemoglobin solutions - where are we going? : more about ... anaemia

USD

 

Abstract

Haemoglobin solutions intended to transport oxygen in the plasma were first conceived and developed as an alternative to red cell transfusion. Although many different haemoglobin formulations have been manufactured and submitted to extensive clinical trials in humans, most of these products have now been abandoned because of safety concerns; only the Biopure product, Hemopure, remains available for clinical use.

Loading

Article metrics loading...

/content/m_cme/26/5/EJC63481
2008-05-01
2016-12-03
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error